Avian Influenza Vaccine Market: How Is Zoonotic H5N1 Human Infection Risk Creating Dual-Use Commercial Vaccine Development?
H5N1 zoonotic spillover's commercial dual-use vaccine development imperative — the documented H5N1 human infections in dairy farm workers across multiple US states in 2024 — with the 2024 US dairy cattle H5N1 outbreak creating documented human exposure through direct cattle contact — alongside the WHO's documentation of human H5N1 cases in Asia and Africa with case fatality...
0 Comments 0 Shares 380 Views 0 Reviews